Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    August 2, 2016August 2, 2016

    Melanoma Screenings for Atypical Moles Should Include Perianal Area

    News
    Patients undergoing melanoma screening and surveillance should be examined in the perianal area for melanocytic nevi, or moles, that are associated with atypical nevi elsewhere on the body, according to researchers at ... Read more
    July 28, 2016July 28, 2016

    Metastatic Melanomas Respond to Immunotherapy Combo in Early Clinical Study

    News
    The immune-therapy drug ipilimumab together with talimogene laherparepvec, or T-VEC, produced positive results in a Phase 1b clinical trial in patients with metastatic melanomas, who did not respond to other ... Read more
    July 26, 2016July 26, 2016

    New Compound Against Sun’s UVA Rays Might Improve Sunscreens

    News
    Developed by United Kingdom researchers, a new compound dubbed “mitoiron claw” can protect cells from UVA radiation in sunlight and might enhance the effects of sunscreen and skin care products that now ... Read more
    July 21, 2016July 21, 2016

    Immunotherapy Approach to Treat Melanoma Looks Promising, Studies Reveal

    News
    Blocking immune checkpoints as well as modifying T-cells could treat melanoma according to two new studies conducted by researchers at the Clinical Research Division of the Fred Hutch Cancer Research ... Read more
    July 19, 2016July 19, 2016

    Researchers Identify How Melanoma Avoids Immune Checkpoints, Potentially Leading to New Therapies

    News
    Researcher at the University of California, Los Angeles (UCLA) have identified new mechanisms used by melanoma cells to avoid being recognized by the immune system and therefore escape it. This ... Read more
    July 14, 2016July 14, 2016

    Melanoma Gene Expression Testing Changed Clinical Treatment for Over Half the Patients Tested, Study Shows

    News
    A design impact study of Castle Biosciences‘ DecisionDx-Melanoma gene expression profile (GEP) test for cutaneous melanoma (CM) was recently published in the journal Current Medical Research and Opinion. The test by Texas-based ... Read more
    July 12, 2016July 12, 2016

    Easier Access to Melanoma Screenings Doesn’t Result in Excessive Treatment, Community Study Reports

    News
    Results from a large-scale melanoma screening conducted in Pennsylvania indicate that, overall, the practice complies with the medical maxim: “first do no harm.” The numbers show that melanoma screenings did ... Read more
    July 7, 2016July 7, 2016

    Medical Cannabis Therapy for Melanoma Being Developed at University of Canberra

    News
    The University of Canberra has signed a $1 million (Australian dollars) collaboration with Cann Pharmaceutical — a joint venture between better Medical Grade Cannabis of Israel and Australia’s Curus Medical — to create a ... Read more
    July 5, 2016July 5, 2016

    Malignant Melanoma Rates Up 155% Among Older Adults in UK Since 1990s

    News
    Cancer Research UK released demographic data this week showing that malignant melanoma rates in the U.K. have more than doubled among people ages 55 and older since the mid-1990s, and are also ... Read more
    June 30, 2016June 30, 2016

    Melanoma Skin Check Partners Help Patients Identify New Cancers

    News
    A recent clinical trial proved that skin-check partners of melanoma patients can successfully assist with skin self-examinations by recognizing new melanomas and increasing early detection of the cancer. The study, “Early Detection of New Melanomas ... Read more
    June 28, 2016June 28, 2016

    Melanoma Identified by Cognitive Technology Closer with IBM, Australian Research

    News
    IBM Research in Australia will conduct new research with Melanoma Institute Australia to help further a plan to use cognitive technology for melanoma identification. The project builds on IBM’s pre-existing agreement with MoleMap – a company that ... Read more
    June 23, 2016June 23, 2016

    Combination Immunotherapy for Melanoma Receives NICE Approval

    News
    The National Institute for Health and Care Excellence (NICE) has approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for patients in England and Wales with metastatic melanoma. Ipilumumab targets the CTLA-4 molecule found ... Read more
    June 16, 2016June 16, 2016

    Early Studies Show Ricolinostat Boosts Immunotherapy Used to Treat Melanoma

    News
    Acetylon Pharmaceuticals announced the publication of two abstracts describing preclinical trials that demonstrated the potential of ricolinostat (ACY-1215), a HDAC6 inhibitor, to augment immunotherapies used to treat melanoma, and plans to start clinical testing in ... Read more
    June 14, 2016June 14, 2016

    Brake Release in Natural Killer (NK) Cells Could Boost Cancer Defenses

    News
    While many scientists have focused on how to make adaptive immune T-cells better fight cancer, Drs. Sandra Nicholson and Nicholas Huntington looked to a subtype of innate immune cells specialized in eliminating ... Read more
    June 9, 2016June 9, 2016

    Radiation, Immunotherapy Combo a Promising Approach Against Melanoma

    News
    Researchers at Loyola University Chicago Stritch School of Medicine have found that the combination of new immunotherapies with radiation therapy offers a promising therapeutic approach for melanoma patients. The study, “The integration ... Read more
    June 7, 2016June 7, 2016

    New Uveal Melanoma Clinical Data Revealed at ASCO 2016

    News
    Castle Biosciences, a manufacturer of molecular diagnostics for cancer treatments, recently revealed current clinical data on a new test designed to predict metastasis in patients with uveal melanoma. The information about ... Read more
    June 2, 2016June 2, 2016

    Researchers Identify Cause for Merkel Skin Cancer, FDA Approved Drug to Stop It

    News, Skin Cancer
    Researchers from the Perelman School of Medicine at the University of Pennsylvania have uncovered a skin cell  predominantly infected by the Merkel cell polyomavirus, which can cause Merkel cell carcinoma ... Read more
    May 26, 2016May 26, 2016

    EC Approves Immuno-Oncology Combination of Opdivo and Yervoy Regimen for Advanced Melanoma

    News
    The European Commission (EC) has approved  the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) in the treatment of patients diagnosed with BRAF V600 wild-type unresectable or metastatic melanoma. This is the first and only combination treatment of two ... Read more
    May 25, 2016May 25, 2016

    2 Metastatic Melanoma Patients Reported to Live Disease-free for Years After Immunotherapy

    News
    A case study reported on two patients with advanced melanoma that had spread to the liver, who experienced progression-free long-term survival — of 4.5 and 12 years — following removal of ... Read more
    May 24, 2016May 24, 2016

    Pembrolizumab Thwarts Advanced Melanoma, Study Reports

    News
    In the largest study ever performed in patients with advanced melanoma, researchers showed that the immunotherapy medication pembrolizumab (Keytruda) put the cancer in regression with treatment effects lasting up to three years. ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.